Figure 2.
First generation of orthosteric mAChR agonists. HTL-9936 (Sosei Heptares, Phase 1 trials) and SPP1 (Eli Lilly, not yet in clinical development) represent recent efforts (brackets) targeting the mAChRs with functional selectivity for M1.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.